"Demand for sequencing consumables and the HiSeq family of instruments remained strong during the quarter, while instrument sales in the desktop family underperformed our expectations," Illumina CEO Jay Flatley said in a statement.
Tuesday, October 6, 2015
Illumina (ILMN) Crashes
Illumina (ILMN) hit a new 52-week low of $130.00 this morning (02015.10.06) and trading has just started. In three months, ILMN has lost 46+% of its market value. Hmm... It almost seems as if the Genomics Age has come an end. Granted, ILMN was a pricey stock, but this crash might be a good buying opportunity for those who would like to add ILMN to their long-term portfolios.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment